betamethasone / salicylic acid
- RxCUI
- 1000711
- RxNorm name
- betamethasone / salicylic acid
- Term type
- MIN
- Status
- Active
- Updated
- 2026-09-09 14:37:40
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- YES
- Branded
- NO
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances#
UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings#
unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.
No records found.
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | S01BC | Antiinflammatory agents, non-steroids | ATC1-4 | | salicylic acid |
| ATC | C05AA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | S03BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | S02BA | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | R01AD | Corticosteroids | ATC1-4 | | betamethasone |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | | betamethasone |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | | betamethasone |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | | betamethasone |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | | betamethasone |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | | betamethasone |
| ATC | R03BA | Glucocorticoids | ATC1-4 | | betamethasone |
| ATC | H02AB | Glucocorticoids | ATC1-4 | | betamethasone |
| ATC | D01AE | Other antifungals for topical use | ATC1-4 | | salicylic acid |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | betamethasone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone |
| MEDRT | D020156 | Salicylic Acid | CHEM | has_ingredient | salicylic acid |
| MEDRT | D000152 | Acne Vulgaris | DISEASE | may_treat | salicylic acid |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | salicylic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | salicylic acid |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone |
| MEDRT | D017492 | Keratosis, Seborrheic | DISEASE | may_treat | salicylic acid |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | salicylic acid |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | salicylic acid |
| MEDRT | D014860 | Warts | DISEASE | may_treat | salicylic acid |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | salicylic acid |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone |
| MEDRT | N0000009974 | Increased Skin Keratinization | PE | has_pe | salicylic acid |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| CODES | SNOMEDCT | 346347008 |
| SOURCES | Source | US Edition of SNOMED_CT |